Terms: = Uterine cancer AND NT5C2, ENSG00000076685, 22978, P49902, PNT5, NT5B, GMP, cN-II AND Prognosis
4 results:
1. Identification of Cytosolic DNA Sensor cGAS-STING as Immune-Related Risk Factor in Renal Carcinoma following Pan-cancer Analysis.
Wu Z; Lin Y; Liu LM; Hou YL; Qin WT; Zhang L; Jiang SH; Yang Q; Bai YR
J Immunol Res; 2022; 2022():7978042. PubMed ID: 35983076
[TBL] [Abstract] [Full Text] [Related]
2. Association of homozygous variants of STING1 with outcome in human cervical cancer.
Lubbers JM; Koopman B; de Klerk-Sluis JM; van Rooij N; Plat A; Pijper H; Koopman T; van Hemel BM; Hollema H; Wisman B; Nijman HW; de Bruyn M
Cancer Sci; 2021 Jan; 112(1):61-71. PubMed ID: 33040406
[TBL] [Abstract] [Full Text] [Related]
3. Genomic profile predicts the efficacy of neoadjuvant chemotherapy for cervical cancer patients.
Horikawa N; Baba T; Matsumura N; Murakami R; Abiko K; Hamanishi J; Yamaguchi K; Koshiyama M; Yoshioka Y; Konishi I
BMC Cancer; 2015 Oct; 15():739. PubMed ID: 26482555
[TBL] [Abstract] [Full Text] [Related]
4. Urinary cyclic gmp after treatment of gynecological cancer. A prognostic marker of clinical outcome.
Orbo A; Hanevik M; Jaeger R; Van Heusden S; Sager G
Anticancer Res; 2007; 27(4C):2591-6. PubMed ID: 17695420
[TBL] [Abstract] [Full Text] [Related]
